Beta1-adrenergic agonist: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
Latest revision as of 14:45, 4 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Beta1-adrenergic agonists, also known as Beta1-adrenergic receptor agonists, are a class of drugs that bind selectively to the beta-1 adrenergic receptor. As a result, they act more selectively upon the heart.
Examples
Examples include denopamine,[1][2] dobutamine, and xamoterol.
References
- ↑ Sakuma T, Hida M, Nambu Y; et al. (2001). "Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs". Jpn. J. Pharmacol. 85 (2): 161–6. PMID 11286398. Unknown parameter
|month=ignored (help) - ↑ Nishio R, Matsumori A, Shioi T; et al. (1998). "Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart". J. Am. Coll. Cardiol. 32 (3): 808–15. PMID 9741531. Unknown parameter
|month=ignored (help)